Waldencast plc (NASDAQ:WALD - Get Free Report) has been given a consensus rating of "Moderate Buy" by the six brokerages that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $5.11.
WALD has been the subject of several analyst reports. Canaccord Genuity Group lowered their target price on Waldencast from $6.00 to $5.00 and set a "buy" rating for the company in a research report on Thursday, May 15th. Industrial Alliance Securities set a $5.00 price objective on Waldencast in a research note on Tuesday, April 22nd. Alliance Global Partners reissued a "buy" rating on shares of Waldencast in a research report on Thursday, May 15th. DA Davidson reaffirmed a "buy" rating and issued a $7.50 price objective on shares of Waldencast in a research note on Wednesday, March 19th. Finally, Wall Street Zen cut shares of Waldencast from a "hold" rating to a "sell" rating in a research report on Thursday.
Read Our Latest Analysis on WALD
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in WALD. Barclays PLC lifted its position in Waldencast by 15.1% in the 4th quarter. Barclays PLC now owns 37,342 shares of the company's stock valued at $150,000 after acquiring an additional 4,906 shares in the last quarter. SG Americas Securities LLC purchased a new position in Waldencast during the fourth quarter worth about $42,000. JPMorgan Chase & Co. grew its position in Waldencast by 52.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 43,250 shares of the company's stock worth $157,000 after purchasing an additional 14,803 shares in the last quarter. Ethic Inc. bought a new stake in Waldencast in the 4th quarter worth about $56,000. Finally, Wells Fargo & Company MN increased its stake in Waldencast by 29.9% in the 4th quarter. Wells Fargo & Company MN now owns 14,571 shares of the company's stock valued at $59,000 after buying an additional 3,358 shares during the last quarter. 41.97% of the stock is owned by institutional investors and hedge funds.
Waldencast Trading Up 0.1%
Shares of WALD stock traded up $0.00 during trading hours on Friday, hitting $2.17. 5,366 shares of the company's stock traded hands, compared to its average volume of 129,321. The stock's 50 day simple moving average is $2.73 and its 200 day simple moving average is $3.16. Waldencast has a 12 month low of $1.98 and a 12 month high of $4.96. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.47 and a quick ratio of 0.78.
Waldencast Company Profile
(
Get Free ReportWaldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
See Also
Before you consider Waldencast, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waldencast wasn't on the list.
While Waldencast currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
